IT Outsourcing in European Life Sciences Industry – Service Provider Landscape with PEAK Matrix™ Assessment 2015

13 Jul 2015
by Abhishek Singh, Jimit Arora, Mayank Maria, Nitish Mittal



The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social media platforms, and “anytime-anywhere” information access).

Global life sciences industry is faced with narrowing margins, expiring patents for blockbuster drugs, dwindling drug pipeline, and rising adoption of personalized medicine as well as wearables. The European industry in particular is witnessing a spike in personalized medicine and several regulatory changes (around drug approvals, medical devices, pharmacovigilance, etc.), compounding the challenges for players in this market and compelling them to reengineer their strategic focus. This, in turn, is triggering the demand for analytics, data consolidation, and infrastructure & application modernization services.

Evolving technology mandate for healthcare enterprises is driving the need for relevant research and market intelligence on demand and supply trends in healthcare outsourcing across the three major market segments – payer, provider, and life sciences. Everest Group’s healthcare outsourcing research program addresses this market requirement by analyzing outsourcing trends and service provider capabilities specific to ITO in the healthcare vertical.

In this report, we analyze the capabilities of 15 leading ITO service providers specific to the European life sciences sector. These service providers are mapped on the Everest Group PEAK Matrix, which is a composite index of a range of distinct metrics related to a service provider’s capability and market success.

PEAK Matrix

Scope of the analysis

  • Industry: Life sciences (pharmaceuticals, biotechnology, and medical devices)
  • Services: Large (TCV >US$25 million), multi-year (>three years), and annuity-based application outsourcing
  • Geography: Europe (including United Kingdom)
  • Sourcing model: Third-party ITO transactions; excludes shared services or captives

Average Revenue


This report is structured across three key sections, each containing insights on the European life sciences ITO service provider landscape, with a specific focus on large-sized contracts:

  • European life sciences ITO market landscape: Analysis of the European life sciences ITO market along the following parameters:
    • Current market opportunity and growth prospects
    • Country analysis; differentiating market dynamics across key European countries
    • European life sciences firms’ IT imperatives
  • European life sciences ITO PEAK Matrix for 2015 and analysis of the different PEAK Matrix clusters:
    • Analysis of service provider capabilities in the life sciences ITO space along delivery capability (scale, scope, domain investments, delivery footprint, innovation, and buyer satisfaction) and market success (transaction activity)
    • Map life sciences ITO service providers on the Everest Group Performance | Experience | Ability | Knowledge (PEAK) Matrix
    • Commentary on the specific characteristics of the PEAK Matrix clusters (Leaders, Major Contenders, and Aspirants)
    • Distinguishing service providers within the European life sciences ITO space
  • Implications for key stakeholders: Implications of the market dynamics and identified European life sciences ITO service provider landscape characteristics for key stakeholders:
    • Implications for service providers
    • Implications for buyers

Everest Group has a complimentary four-page PEAK Matrix preview document for this service provider landscape report.


Page Count: 64